Stephen J. Atkinson

2.1k total citations
15 papers, 535 citations indexed

About

Stephen J. Atkinson is a scholar working on Molecular Biology, Organic Chemistry and Hematology. According to data from OpenAlex, Stephen J. Atkinson has authored 15 papers receiving a total of 535 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Organic Chemistry and 5 papers in Hematology. Recurrent topics in Stephen J. Atkinson's work include Protein Degradation and Inhibitors (6 papers), Multiple Myeloma Research and Treatments (4 papers) and Histone Deacetylase Inhibitors Research (4 papers). Stephen J. Atkinson is often cited by papers focused on Protein Degradation and Inhibitors (6 papers), Multiple Myeloma Research and Treatments (4 papers) and Histone Deacetylase Inhibitors Research (4 papers). Stephen J. Atkinson collaborates with scholars based in United Kingdom, Germany and United States. Stephen J. Atkinson's co-authors include Robert P. Law, Allan J. B. Watson, Albert Isidro‐Llobet, Julien C. Vantourout, Rab K. Prinjha, Chun‐wa Chung, Charles M. Marson, N. Shaun B. Thomas, Laurie Gordon and Emmanuel H. Demont and has published in prestigious journals such as Journal of Medicinal Chemistry, International Journal of Radiation Oncology*Biology*Physics and The Journal of Organic Chemistry.

In The Last Decade

Stephen J. Atkinson

15 papers receiving 528 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephen J. Atkinson United Kingdom 12 296 296 78 76 45 15 535
Neil Pegg United Kingdom 14 274 0.9× 221 0.7× 29 0.4× 84 1.1× 16 0.4× 39 465
N. Chessum United Kingdom 10 155 0.5× 181 0.6× 28 0.4× 54 0.7× 18 0.4× 11 335
Yuri Bolshan Canada 13 406 1.4× 305 1.0× 20 0.3× 25 0.3× 105 2.3× 22 619
Marielle Paris France 11 369 1.2× 576 1.9× 15 0.2× 184 2.4× 17 0.4× 20 662
Alison E. McGonagle United Kingdom 9 181 0.6× 329 1.1× 15 0.2× 125 1.6× 34 0.8× 11 492
Koen F. W. Hekking Netherlands 10 156 0.5× 160 0.5× 27 0.3× 56 0.7× 55 1.2× 10 294
Peter D. Kane United Kingdom 12 413 1.4× 152 0.5× 29 0.4× 14 0.2× 43 1.0× 22 495
Helen J. Mason United Kingdom 11 173 0.6× 120 0.4× 16 0.2× 27 0.4× 25 0.6× 18 286
Lan Trinh United States 11 215 0.7× 170 0.6× 59 0.8× 27 0.4× 8 0.2× 17 381
Nalin L. Subasinghe United States 12 238 0.8× 198 0.7× 18 0.2× 49 0.6× 10 0.2× 17 419

Countries citing papers authored by Stephen J. Atkinson

Since Specialization
Citations

This map shows the geographic impact of Stephen J. Atkinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen J. Atkinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen J. Atkinson more than expected).

Fields of papers citing papers by Stephen J. Atkinson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen J. Atkinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen J. Atkinson. The network helps show where Stephen J. Atkinson may publish in the future.

Co-authorship network of co-authors of Stephen J. Atkinson

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen J. Atkinson. A scholar is included among the top collaborators of Stephen J. Atkinson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen J. Atkinson. Stephen J. Atkinson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Atkinson, Stephen J., et al.. (2022). A patent review of MAT2a inhibitors (2018–2021). Expert Opinion on Therapeutic Patents. 32(10). 1043–1053. 10 indexed citations
2.
Atkinson, Stephen J., Chun‐wa Chung, Paola Grandi, et al.. (2021). Discovery of a Highly Selective BET BD2 Inhibitor from a DNA-Encoded Library Technology Screening Hit. Journal of Medicinal Chemistry. 64(15). 10806–10833. 33 indexed citations
3.
Lucas, Simon C. C., Stephen J. Atkinson, Chun‐wa Chung, et al.. (2021). Optimization of a Series of 2,3-Dihydrobenzofurans as Highly Potent, Second Bromodomain (BD2)-Selective, Bromo and Extra-Terminal Domain (BET) Inhibitors. Journal of Medicinal Chemistry. 64(15). 10711–10741. 20 indexed citations
4.
Lucas, Simon C. C., Stephen J. Atkinson, Paul Bamborough, et al.. (2020). Optimization of Potent ATAD2 and CECR2 Bromodomain Inhibitors with an Atypical Binding Mode. Journal of Medicinal Chemistry. 63(10). 5212–5241. 16 indexed citations
5.
Law, Robert P., Stephen J. Atkinson, Paul Bamborough, et al.. (2018). Discovery of Tetrahydroquinoxalines as Bromodomain and Extra-Terminal Domain (BET) Inhibitors with Selectivity for the Second Bromodomain. Journal of Medicinal Chemistry. 61(10). 4317–4334. 85 indexed citations
6.
Lucas, Simon C. C., et al.. (2018). Alkene Oxyamination Using Malonoyl Peroxides: Preparation of Pyrrolidines and Isoxazolidines. The Journal of Organic Chemistry. 83(12). 6728–6740. 18 indexed citations
7.
Atkinson, Stephen J., et al.. (2016). OC-031 A Genome-Wide Association Study Identifies PNPLA3 and SLC38A4 as Risk Loci for Alcoholic Hepatitis. A19.1–A19. 1 indexed citations
8.
Vantourout, Julien C., Robert P. Law, Albert Isidro‐Llobet, Stephen J. Atkinson, & Allan J. B. Watson. (2016). Chan–Evans–Lam Amination of Boronic Acid Pinacol (BPin) Esters: Overcoming the Aryl Amine Problem. The Journal of Organic Chemistry. 81(9). 3942–3950. 106 indexed citations
9.
Marson, Charles M., et al.. (2015). Potent and Selective Inhibitors of Histone Deacetylase-3 Containing Chiral Oxazoline Capping Groups and a N-(2-Aminophenyl)-benzamide Binding Unit. Journal of Medicinal Chemistry. 58(17). 6803–6818. 51 indexed citations
10.
Atkinson, Stephen J., Peter E. Soden, Marcus Bantscheff, et al.. (2014). The structure based design of dual HDAC/BET inhibitors as novel epigenetic probes. MedChemComm. 5(3). 342–351. 58 indexed citations
11.
Marson, Charles M., et al.. (2013). Discovery of Potent, Isoform-Selective Inhibitors of Histone Deacetylase Containing Chiral Heterocyclic Capping Groups and aN-(2-Aminophenyl)benzamide Binding Unit. Journal of Medicinal Chemistry. 56(15). 6156–6174. 50 indexed citations
12.
Paterson, Ian, et al.. (2013). Total Synthesis of Aplyronine C. Organic Letters. 15(12). 3118–3121. 27 indexed citations
13.
Hall, Adrian, Stephen J. Atkinson, Susan H. Brown, et al.. (2006). Structure–activity relationships of 1,5-biaryl pyrroles as EP1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 16(14). 3657–3662. 21 indexed citations
14.
Hall, Adrian, Stephen J. Atkinson, Susan H. Brown, et al.. (2006). Discovery of novel, non-acidic 1,5-biaryl pyrrole EP1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 17(5). 1200–1205. 38 indexed citations
15.
Hossain, Md. Kamal, et al.. (2005). Systemically Administered Erythropoietin Protects the Irradiated Brain Through Anti-Inflammatory Mechanisms. International Journal of Radiation Oncology*Biology*Physics. 63. S87–S87. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026